| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATG5
|
autophagy related 5
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN8
|
ataxin 8
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
C3
|
complement component 3
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALB1
|
calbindin 1, 28kDa
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAST
|
calpastatin
|
|
CCDC62
|
coiled-coil domain containing 62
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CD14
|
CD14 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDNF
|
cerebral dopamine neurotrophic factor
|
|
CFH
|
complement factor H
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTSL
|
cathepsin L
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
E2F1
|
E2F transcription factor 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
EN1
|
engrailed homeobox 1
|
|
EN2
|
engrailed homeobox 2
|
|
ENDOG
|
endonuclease G
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXO7
|
F-box protein 7
|
|
FGB
|
fibrinogen beta chain
|
|
FGF20
|
fibroblast growth factor 20
|
|
FGG
|
fibrinogen gamma chain
|
|
FMR1
|
fragile X mental retardation 1
|
|
FRAXA
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
FRAXE
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
FTMT
|
ferritin mitochondrial
|
|
FUS
|
FUS RNA binding protein
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAK
|
cyclin G associated kinase
|
|
GBA
|
glucosidase, beta, acid
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GLA
|
galactosidase, alpha
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HFE
|
hemochromatosis
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNMT
|
histamine N-methyltransferase
|
|
HP
|
haptoglobin
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HSP90AB2P
|
heat shock protein 90kDa alpha (cytosolic), class B member 2, pseudogene
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LINGO2
|
leucine rich repeat and Ig domain containing 2
|
|
LMX1A
|
LIM homeobox transcription factor 1, alpha
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LPO
|
lactoperoxidase
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCCC1
|
methylcrotonoyl-CoA carboxylase 1 (alpha)
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MIR133B
|
microRNA 133b
|
|
MIR205
|
microRNA 205
|
|
MIR433
|
microRNA 433
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR7-2
|
microRNA 7-2
|
|
MIR7-3
|
microRNA 7-3
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT-ND2
|
MTND2
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTIF3
|
mitochondrial translational initiation factor 3
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
ND1
|
|
|
NDFIP1
|
Nedd4 family interacting protein 1
|
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
|
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NPTX2
|
neuronal pentraxin II
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OTX2
|
orthodenticle homeobox 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PACRG
|
PARK2 co-regulated
|
|
PARK12
|
Parkinson disease 12 (susceptibility)
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK3
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
PARK7
|
parkinson protein 7
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDYN
|
prodynorphin
|
|
PER1
|
period circadian clock 1
|
|
PHACTR2
|
phosphatase and actin regulator 2
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX3
|
paired-like homeodomain 3
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLXNA4
|
plexin A4
|
|
PMEL
|
premelanosome protein
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPHLN1
|
periphilin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX5
|
peroxiredoxin 5
|
|
PSMB4
|
proteasome (prosome, macropain) subunit, beta type, 4
|
|
PSMC1
|
proteasome (prosome, macropain) 26S subunit, ATPase, 1
|
|
PSMC4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTX3
|
pentraxin 3, long
|
|
PVALB
|
parvalbumin
|
|
RAB29
|
RAB29, member RAS oncogene family
|
|
RET
|
ret proto-oncogene
|
|
RIT2
|
Ras-like without CAAX 2
|
|
RNF11
|
ring finger protein 11
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
RPS15
|
ribosomal protein S15
|
|
RTN3
|
reticulon 3
|
|
S100B
|
S100 calcium binding protein B
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT5
|
sirtuin 5
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SNCB
|
synuclein, beta
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SST
|
somatostatin
|
|
STH
|
saitohin
|
|
STX6
|
syntaxin 6
|
|
SYT11
|
synaptotagmin XI
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBP
|
TATA box binding protein
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFR2
|
transferrin receptor 2
|
|
TFRC
|
transferrin receptor
|
|
TGM2
|
transglutaminase 2
|
|
TH
|
tyrosine hydroxylase
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TP53
|
tumor protein p53
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTR
|
transthyretin
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VPS26A
|
vacuolar protein sorting 26 homolog A (S. pombe)
|
|
VPS29
|
vacuolar protein sorting 29 homolog (S. cerevisiae)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VPS41
|
vacuolar protein sorting 41 homolog (S. cerevisiae)
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
